448 related articles for article (PubMed ID: 6205747)
21. HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta.
Shaw AR; Chan JK; Reid S; Seehafer J
J Natl Cancer Inst; 1985 Jun; 74(6):1261-8. PubMed ID: 3923246
[TBL] [Abstract][Full Text] [Related]
22. Comparison of cell-surface human melanoma-associated antigens identified by rabbit and murine antibodies.
Bystryn JC; Jacobsen JS; Liu P; Heaney-Kieras J
Hybridoma; 1982; 1(4):465-72. PubMed ID: 6208141
[TBL] [Abstract][Full Text] [Related]
23. Heterogeneity of HLA-A,B, Ia-like, and melanoma-associated antigen expression by human melanoma cell lines analyzed with monoclonal antibodies and flow cytometry.
Burchiel SW; Martin JC; Imai K; Ferrone S; Warner NL
Cancer Res; 1982 Oct; 42(10):4110-5. PubMed ID: 7049355
[TBL] [Abstract][Full Text] [Related]
24. Differential extraction of tumor-specific transplantation antigen and embryonic antigen from simian virus 40- and adenovirus 7-induced sarcoma cells of hamsters with 1-butanol and 3 M potassium chloride.
Coggin JH; Gillis LD; Payne WJ
J Natl Cancer Inst; 1984 Apr; 72(4):853-62. PubMed ID: 6323810
[TBL] [Abstract][Full Text] [Related]
25. Extraction of human organ-specific cancer neoantigens from cancer cells and plasma membranes with 1-butanol.
Labateya N; Thomson DM; Durko M; Shenouda G; Robb L; Scanzano R
Cancer Res; 1987 Feb; 47(4):1058-64. PubMed ID: 3100029
[TBL] [Abstract][Full Text] [Related]
26. Malignant melanoma: cross-reacting (common) tumor rejection antigens.
Hearing VJ; Vieira WD; Law LW
Int J Cancer; 1985 Mar; 35(3):403-9. PubMed ID: 2579039
[TBL] [Abstract][Full Text] [Related]
27. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
de Vries JE; Spits H
J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
[TBL] [Abstract][Full Text] [Related]
28. Discoordinate surface expression of IFN-gamma-induced HLA class II proteins in nonprofessional antigen-presenting cells with absence of DM and class II colocalization.
Muczynski KA; Anderson SK; Pious D
J Immunol; 1998 Apr; 160(7):3207-16. PubMed ID: 9531276
[TBL] [Abstract][Full Text] [Related]
29. Interferon-gamma regulates the T cell response to precursor nevi and biologically early melanoma.
Guerry D; Alexander MA; Elder DE; Herlyn MF
J Immunol; 1987 Jul; 139(1):305-12. PubMed ID: 3108402
[TBL] [Abstract][Full Text] [Related]
30. Differential expression of melanoma-associated antigens and molecules involved in antigen processing and presentation in three cell lines established from a single patient.
Kovalcsik E; John J; Turner M; Birchall L; Sage D; Whittle R; Dalgleish A; Pandha H
Melanoma Res; 2004 Dec; 14(6):463-71. PubMed ID: 15577316
[TBL] [Abstract][Full Text] [Related]
31. Recombinant gamma-interferon induces changes in expression and shedding of antigens associated with normal human melanocytes, nevus cells, and primary and metastatic melanoma cells.
Herlyn M; Guerry D; Koprowski H
J Immunol; 1985 Jun; 134(6):4226-30. PubMed ID: 2985706
[TBL] [Abstract][Full Text] [Related]
32. Clonal variation in expression of p97 antigen in human melanoma cell lines detected by mixed passive hemagglutination.
Saida T; Uno A
J Dermatol; 1987 Jun; 14(3):201-6. PubMed ID: 3312336
[No Abstract] [Full Text] [Related]
33. Differential modulation by tumor necrosis factor and immune interferon of HLA class-II antigens expressed by melanoma cells.
Maio M; Gulwani B; Morgano A; Ferrone S
Int J Cancer; 1989 Sep; 44(3):554-9. PubMed ID: 2506138
[TBL] [Abstract][Full Text] [Related]
34. HLA-DR and melanoma-associated antigen (p97) expression during the cell cycle in human melanoma cell lines, and the effects of recombinant gamma-interferon: two-color flow cytometric analysis.
Kameyama K; Takezaki S; Kanzaki T; Nishiyama S
J Invest Dermatol; 1986 Sep; 87(3):313-8. PubMed ID: 3090158
[TBL] [Abstract][Full Text] [Related]
35. Serological and biochemical analyses of monoclonal antibodies to human melanoma-associated antigens.
Harper JR; Bumol TF; Reisfeld RA
Hybridoma; 1982; 1(4):423-32. PubMed ID: 6208137
[TBL] [Abstract][Full Text] [Related]
36. Functional association of class II antigens with cell surface binding of Epstein-Barr virus.
Reisert PS; Spiro RC; Townsend PL; Stanford SA; Sairenji T; Humphreys RE
J Immunol; 1985 Jun; 134(6):3776-80. PubMed ID: 2985696
[TBL] [Abstract][Full Text] [Related]
37. Surface antigenic profile of uveal melanoma lesions analysed with a panel of monoclonal antibodies directed against cutaneous melanoma.
Carrel S; Schreyer M; Gross N; Zografos L
Anticancer Res; 1990; 10(1):81-9. PubMed ID: 1692197
[TBL] [Abstract][Full Text] [Related]
38. Retrovirally transduced human dendritic cells can generate T cells recognizing multiple MHC class I and class II epitopes from the melanoma antigen glycoprotein 100.
Lapointe R; Royal RE; Reeves ME; Altomare I; Robbins PF; Hwu P
J Immunol; 2001 Oct; 167(8):4758-64. PubMed ID: 11591807
[TBL] [Abstract][Full Text] [Related]
39. HLA-DR antigens of autologous melanoma and B lymphoblastoid cell lines: differences in glycosylation but not protein structure.
Alexander S; Hubbard SC; Strominger JL
J Immunol; 1984 Jul; 133(1):315-20. PubMed ID: 6609984
[TBL] [Abstract][Full Text] [Related]
40. Isolation of novel HLA-DR restricted potential tumor-associated antigens from the melanoma cell line FM3.
Halder T; Pawelec G; Kirkin AF; Zeuthen J; Meyer HE; Kun L; Kalbacher H
Cancer Res; 1997 Aug; 57(15):3238-44. PubMed ID: 9242455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]